SPRY position history
The shares of Ars Pharmaceuticals (SPRY) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 40,000 shares, $698K, <0.01% of portfolio, New
- 2025 Q3: 1,268,532 shares, $13M, 0.03% of portfolio, Add +3071.3%
- 2025 Q4: 1,268,532 shares, $15M, 0.04% of portfolio
- 2026 Q1: 1,273,341 shares, $10M, 0.03% of portfolio, Add +0.4%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|